Literature DB >> 8560700

Portal hypertension associated with primary hypoplasia of the hepatic portal vein in dogs.

T S Van den Ingh1, J Rothuizen, H P Meyer.   

Abstract

Portal hypertension caused by primary hypoplasia of the portal vein was diagnosed in 42 dogs. The portal hypertension was manifested by the presence of multiple portosystemic collateral vessels. The main clinical signs were retarded growth or weight loss, apathy, intermittent diarrhoea and vomiting, anorexia, abdominal distension and polydipsia. Major findings at physical examination were ascites in 23 dogs and neurological signs in 16 dogs. The dogs had increased activities of liver enzymes in plasma and increased fasting levels of total bile acids and ammonia; in many of the dogs the packed red cell volume, total serum protein and albumin were low. Gross inspection of the portal vein revealed a patent but underdeveloped extrahepatic vein in 13 of the dogs. Microscopic examination of the liver revealed hypoplasia of the intrahepatic portal veins in all the dogs, and this was associated with minor arteriolar proliferation and absence of fibrosis in 12 of them, with moderate to marked arteriolar proliferation often combined with ductular proliferation in 13, and with marked portal fibrosis (formerly described as hepatoportal fibrosis) with a varying number of arteriolar and bile ductular structures in 17 of the dogs. The disease affected mainly young dogs, and was most likely to have been of congenital origin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8560700     DOI: 10.1136/vr.137.17.424

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  9 in total

1.  Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment.

Authors:  Bart Spee; Louis C Penning; Ted S G A M van den Ingh; Brigitte Arends; Jooske Ijzer; Frederik J van Sluijs; Jan Rothuizen
Journal:  Comp Hepatol       Date:  2005-12-07

2.  A retrospective histopathological survey on canine and feline liver diseases at the University of Tokyo between 2006 and 2012.

Authors:  Naoki Hirose; Kazuyuki Uchida; Hideyuki Kanemoto; Koichi Ohno; James K Chambers; Hiroyuki Nakayama
Journal:  J Vet Med Sci       Date:  2014-04-09       Impact factor: 1.267

3.  Splenophrenic portosystemic shunt in dogs with and without portal hypertension: can acquired and congenital porto-caval connections coexist?

Authors:  M Ricciardi
Journal:  Open Vet J       Date:  2016-11-05

4.  Clinicopathological Findings and Prognosis in Canine Cases Diagnosed As Primary Hypoplasia of the Portal Vein.

Authors:  Makoto Akiyoshi; Masaharu Hisasue; Masami Akiyoshi
Journal:  Front Vet Sci       Date:  2017-12-21

5.  Portal Vein/Aorta Ratio in Dogs with Acquired Portosystemic Collaterals.

Authors:  Y Sakamoto; M Sakai; T Watari
Journal:  J Vet Intern Med       Date:  2017-08-14       Impact factor: 3.333

6.  Unusual haemodynamics in two dogs and two cats with portosystemic shunt - implications for distinguishing between congenital and acquired conditions.

Authors:  Mario Ricciardi
Journal:  Open Vet J       Date:  2017-04-19

7.  Multiple acquired portosystemic shunts secondary to primary hypoplasia of the portal vein in a cat.

Authors:  Satoko Sugimoto; Shingo Maeda; Masaya Tsuboi; Kohei Saeki; James K Chambers; Tomohiro Yonezawa; Kenjiro Fukushima; Reina Fujiwara; Kazuyuki Uchida; Hajime Tsujimoto; Naoaki Matsuki; Koichi Ohno
Journal:  J Vet Med Sci       Date:  2018-04-09       Impact factor: 1.267

8.  Efficacy of orally administered sodium benzoate and sodium phenylbutyrate in dogs with congenital portosystemic shunts.

Authors:  Giora van Straten; Diewke van Dalen; Sietske J Mesu; Jan Rothuizen; Erik Teske; Bart Spee; Robert P Favier; Ingeborg M van Geijlswijk
Journal:  J Vet Intern Med       Date:  2019-03-27       Impact factor: 3.333

9.  Gallbladder Agenesis in 17 Dogs: 2006-2016.

Authors:  K Sato; M Sakai; S Hayakawa; Y Sakamoto; Y Kagawa; K Kutara; K Teshima; K Asano; T Watari
Journal:  J Vet Intern Med       Date:  2018-01       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.